Skip to main content
. 2020 Feb 6;12(3):2302–2332. doi: 10.18632/aging.102746

Figure 6.

Figure 6

Expression of T-cell and immune checkpoint markers in low-risk and high-risk patients. Group differences were assessed by Wilcoxon test.